<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Hereditary_hemochromatosis</id>
	<title>Hereditary hemochromatosis - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Hereditary_hemochromatosis"/>
	<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Hereditary_hemochromatosis&amp;action=history"/>
	<updated>2026-05-13T00:35:04Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://idwiki.org/index.php?title=Hereditary_hemochromatosis&amp;diff=5120&amp;oldid=prev</id>
		<title>Aidan: Text replacement - &quot;Clinical Presentation&quot; to &quot;Clinical Manifestations&quot;</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Hereditary_hemochromatosis&amp;diff=5120&amp;oldid=prev"/>
		<updated>2020-07-21T01:44:45Z</updated>

		<summary type="html">&lt;p&gt;Text replacement - &amp;quot;Clinical Presentation&amp;quot; to &amp;quot;Clinical Manifestations&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 01:44, 21 July 2020&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 20:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 20:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* 10% of those homozygous for C282Y develop symptoms&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* 10% of those homozygous for C282Y develop symptoms&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Clinical &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Presentation&lt;/del&gt; ==&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Clinical &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Manifestations&lt;/ins&gt; ==&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== History ===&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=== History ===&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
	<entry>
		<id>https://idwiki.org/index.php?title=Hereditary_hemochromatosis&amp;diff=4253&amp;oldid=prev</id>
		<title>Maintenance script: Imported from text file</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Hereditary_hemochromatosis&amp;diff=4253&amp;oldid=prev"/>
		<updated>2020-07-04T01:17:38Z</updated>

		<summary type="html">&lt;p&gt;Imported from text file&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Definition ==&lt;br /&gt;
&lt;br /&gt;
Recessive genetic disorder to iron handling that is characterized by elevated iron saturation and high ferritin and that causes progressive end-organ damage, most commonly liver, pancreas, and heart.&lt;br /&gt;
&lt;br /&gt;
== Etiology ==&lt;br /&gt;
&lt;br /&gt;
* Most commonly caused by homozygous C282Y mutation of the HFE gene&lt;br /&gt;
** Only 10% of homozygotes will have iron overload&lt;br /&gt;
* Can also present in compound heterozygotes of HFE gene&lt;br /&gt;
* Non-HFE-associated iron overload&lt;br /&gt;
** Hemojuvelin (HJV)&lt;br /&gt;
** Transferrin receptor-2 (TfR2)&lt;br /&gt;
** Ferroportin (SLC40A1)&lt;br /&gt;
** Hepcidin (HAMP)&lt;br /&gt;
** African iron overload&lt;br /&gt;
&lt;br /&gt;
== Epidemiology ==&lt;br /&gt;
&lt;br /&gt;
* Most common genetic cause of cirrhosis&lt;br /&gt;
* 10% of those homozygous for C282Y develop symptoms&lt;br /&gt;
&lt;br /&gt;
== Clinical Presentation ==&lt;br /&gt;
&lt;br /&gt;
=== History ===&lt;br /&gt;
&lt;br /&gt;
* Asymptomatic&lt;br /&gt;
** Abnormal serum iron studies on routine screening chemistry panel&lt;br /&gt;
** Evaluation of abnormal liver tests&lt;br /&gt;
** Identified by family screening&lt;br /&gt;
* Nonspecific, systemic symptoms&lt;br /&gt;
** Weakness&lt;br /&gt;
** Fatigue&lt;br /&gt;
** Lethargy&lt;br /&gt;
** Apathy&lt;br /&gt;
** Weight loss&lt;br /&gt;
* Specific, organ-related symptoms&lt;br /&gt;
** Abdominal pain (hepatomegaly)&lt;br /&gt;
** Arthralgias (arthritis)&lt;br /&gt;
** Diabetes (pancreas)&lt;br /&gt;
** Amenorrhea (cirrhosis)&lt;br /&gt;
** Loss of libido, impotence (pituitary, cirrhosis)&lt;br /&gt;
** Congestive heart failure&lt;br /&gt;
** Arrhythmias&lt;br /&gt;
&lt;br /&gt;
=== Physical exam ===&lt;br /&gt;
&lt;br /&gt;
* Liver&lt;br /&gt;
** Hepatomegaly&lt;br /&gt;
** Cutaneous stigmata of chronic liver disease&lt;br /&gt;
** Splenomegaly&lt;br /&gt;
** Liver failure: ascites, encephalopathy, and associated features&lt;br /&gt;
* Joints Arthritis&lt;br /&gt;
** Joint swelling&lt;br /&gt;
** Chondrocalcinosis&lt;br /&gt;
* Heart&lt;br /&gt;
** Dilated cardiomyopathy&lt;br /&gt;
** Congestive heart failure&lt;br /&gt;
* Skin&lt;br /&gt;
** Increased pigmentation&lt;br /&gt;
** Porphyria cutanea tarda&lt;br /&gt;
* Endocrine&lt;br /&gt;
** Testicular atrophy&lt;br /&gt;
** Hypogonadism&lt;br /&gt;
** Hypothyroidism&lt;br /&gt;
&lt;br /&gt;
== Investigations ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;pre class=&amp;quot;mermaid&amp;quot;&amp;gt;graph TD;&lt;br /&gt;
&lt;br /&gt;
invest[&amp;amp;quot;Serum transferrin saturation (TS) and ferritin&amp;amp;quot;]&lt;br /&gt;
&lt;br /&gt;
tsnorm[&amp;amp;quot;TS &amp;amp;lt;45% and normal ferritin&amp;amp;quot;]&lt;br /&gt;
tsup[&amp;amp;quot;TS ≥45% and/or high ferritin&amp;amp;quot;]&lt;br /&gt;
fhx[&amp;amp;quot;First-degree relative with HH&amp;amp;quot;]&lt;br /&gt;
noeval[&amp;amp;quot;No further evaluation&amp;amp;quot;]&lt;br /&gt;
genotype[&amp;amp;quot;HFE genotyping&amp;amp;quot;]&lt;br /&gt;
&lt;br /&gt;
invest --&amp;amp;gt; tsnorm&lt;br /&gt;
tsnorm --&amp;amp;gt; noeval&lt;br /&gt;
&lt;br /&gt;
invest --&amp;amp;gt; tsup&lt;br /&gt;
tsup --&amp;amp;gt; genotype&lt;br /&gt;
&lt;br /&gt;
fhx --&amp;amp;gt; genotype&lt;br /&gt;
&amp;lt;/pre&amp;gt;&lt;br /&gt;
* Initial workup is &amp;#039;&amp;#039;&amp;#039;ferritin&amp;#039;&amp;#039;&amp;#039; and &amp;#039;&amp;#039;&amp;#039;serum transferrin saturation&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
** If ferritin is above upper limit of normal, or if transferrin saturation is ≥45%, then do HFE mutation analysis&lt;br /&gt;
** Transferrin saturation = serum iron concentration ÷ total iron binding capacity&lt;br /&gt;
* HFE mutation analysis&lt;br /&gt;
** Done for all first-degree relatives of an index case&lt;br /&gt;
** Done for all patients with elevated ferriting or TS ≥45%&lt;br /&gt;
** Important results:&lt;br /&gt;
*** Homozygous C282Y&lt;br /&gt;
*** Compound heterozygous C282Y/H63D&lt;br /&gt;
*** Homozygous H63D/H63D generally don&amp;#039;t have iron overload&lt;br /&gt;
* Iron/transferrin saturation &amp;amp;gt;60% in men or &amp;amp;gt;50% in women&lt;br /&gt;
** Most sensitive and cost-effective test&lt;br /&gt;
* If cirrhosis develops, monitor closely for hepatocellular carcinoma&lt;br /&gt;
&lt;br /&gt;
== Management ==&lt;br /&gt;
&lt;br /&gt;
* Phlebotomy to target ferritin of 50-100&lt;br /&gt;
** But need to prevent hematocrit or hemoglobin dropping more than 20% of prior level&lt;br /&gt;
&lt;br /&gt;
== Further Reading ==&lt;br /&gt;
&lt;br /&gt;
* Bacon BR &amp;#039;&amp;#039;et al&amp;#039;&amp;#039;. [https://doi.org/10.1002/hep.24330 Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases]. &amp;#039;&amp;#039;Hepatology&amp;#039;&amp;#039;. 2011;54(1):328-43.&lt;br /&gt;
&lt;br /&gt;
[[Category:Hematology]]&lt;br /&gt;
[[Category:Gastroenterology]]&lt;/div&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
</feed>